DR Matthews, A Tsapas - Diabetes and Vascular Disease Research, 2008 - dvdres.com Controversy has dogged trials of glycaemia in type 2 diabetes. The first
substantial trial was the University Group Diabetes Programme (UGDP), which was
published in 1970.1 In a group which comprised patients on tolbutamide ... Cited by 5 - Related articles - View as HTML - All 4 versions
JI Lee, HS Kwon, SJ Oh, JM Lee, SA Chang, … - synapse.koreamed.org Cardiovascular disease (CVD) is the major cause of mortality in type 2 diabetes
mellitus. CVD is a clinical manifestation of atherosclerosis, a chronic and
progressive inflammatory disease characterized by a long asymptomatic ... Related articles - Cached - All 2 versions
N Emanuele, T Moritz, R Klein, MD Davis, K … - Diabetes Research and Clinical Practice, 2009 - Elsevier Hispanics (H) made up 17.5% and African Americans (AA) 17.7% of the cohort. CSME
prevalence was 10%. In univariate analysis, CSME was more prevalent in H, 18%,
and AA, 15.6% than in non-Hispanic Whites (NHW), 6.3%, p < 0.01. Univariate ... Related articles - All 2 versions
T Nissen - Diabetes & Vascular Disease Research - dvr.sagepub.com C ontroversy has dogged trials of glycaemia in type 2 diabetes. The first
substantial trial was the University Group Diabetes Programme (UGDP), which was
published in 1970. 1 In a group which comprised patients on tolbutamide ... Related articles - All 3 versions
JA Gimeno-Orna, E Faure-Nogueras, FJ … - The American Journal of Cardiology, 2009 - Elsevier It is important identify patients with very high cardiovascular risk to
intensify their therapy. Our aim was to assess the association between
retinopathy and incident cardiovascular events (cardiovascular disease ... Related articles - All 35 versions
이주영， 최연경， 서현애， 전재한， 이정은， … - synapse.koreamed.org Page 1. Korean Diabetes J 33:289~298, 2009 DOI : 10.4093/kdj.2009.33.
4.289 ORIGINAL ARTICLES 289 서 론 심혈관질환, 특히 ... Related articles - View as HTML - All 2 versions